… system," Kevin Kaiserman, MD, MannKind senior vice president and therapeutic … the American Diabetes Association's Standards of Care. References MannKind announces … –17 years living with diabetes. News release. MannKind. October 13, 2025. Accessed …

… and teenagers living with diabetes a potential alternative … for Pediatric and Adolescent Diabetes (ISPAD) meeting in … treatment option for adults with diabetes. Michael Haller, MD, … Haller discuss Afrezza. Reference MannKind. MannKind Announces U.S. FDA …

MannKind Corporation has announced the … children and teenagers living with diabetes a potential alternative therapy to … Area Head, Endocrine Diseases at MannKind Corporation, said in a statement … in the press release from MannKind, the submission also included …

… human inhalation powder (Afrezza; MannKind) demonstrated safe and effective replacement … glycemic control in adults with diabetes and recently demonstrated improvements … for children with diabetes, providing an additional treatment …

… Society for Pediatric and Adolescent Diabetes (ISPAD) in early November. Afrezza …  Afrezza.com/safety. About MannKind MannKind Corporation (Nasdaq: MNKD) is a … serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload …

… listed on the Nasdaq. About MannKind MannKind Corporation (Nasdaq: MNKD) is … serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid … of United Therapeutics Corporation. MannKind Contacts:         Media Relations         Christie …

… meaningful growth opportunities, combining MannKind’s endocrinology expertise and infrastructure … listed on the Nasdaq. About MannKind MannKind Corporation (Nasdaq: MNKD) is … serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid …

… franchise, with a focus on diabetes and cardiovascular disease. Dr. Ahuja … on his industry career. About MannKind MannKind Corporation (Nasdaq: MNKD) focuses on … burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease …

… of technosphere insulin (Afrezza, MannKind Corp.). In the first … and clinical director of Integrated Diabetes Services in Wynnewood, Pennsylvania … ? Scheiner: I think MannKind knows that they are … The research was funded by MannKind Corp. Scheiner reports no …

… Perspectives! In this episode of Diabetes Dialogue: Technology, Therapeutics, and … program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …